ATE163933T1 - Verbindungen, nützlich als leukotriene antagonisten - Google Patents
Verbindungen, nützlich als leukotriene antagonistenInfo
- Publication number
- ATE163933T1 ATE163933T1 AT92309461T AT92309461T ATE163933T1 AT E163933 T1 ATE163933 T1 AT E163933T1 AT 92309461 T AT92309461 T AT 92309461T AT 92309461 T AT92309461 T AT 92309461T AT E163933 T1 ATE163933 T1 AT E163933T1
- Authority
- AT
- Austria
- Prior art keywords
- chem
- hydrogen
- compounds useful
- leukotriene antagonists
- alkyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000003199 leukotriene receptor blocking agent Substances 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 5
- 239000001257 hydrogen Substances 0.000 abstract 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000003831 tetrazolyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Reproductive Health (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919122590A GB9122590D0 (en) | 1991-10-24 | 1991-10-24 | Pharmaceutical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE163933T1 true ATE163933T1 (de) | 1998-03-15 |
Family
ID=10703466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92309461T ATE163933T1 (de) | 1991-10-24 | 1992-10-16 | Verbindungen, nützlich als leukotriene antagonisten |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5410061A (de) |
| EP (1) | EP0539117B1 (de) |
| JP (1) | JPH05345778A (de) |
| AT (1) | ATE163933T1 (de) |
| CA (1) | CA2081133A1 (de) |
| DE (1) | DE69224697T2 (de) |
| DK (1) | DK0539117T3 (de) |
| ES (1) | ES2113927T3 (de) |
| GB (1) | GB9122590D0 (de) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3578495A (en) * | 1994-09-30 | 1996-04-26 | Nippon Chemiphar Co. Ltd. | Quinoline derivative |
| TW527186B (en) * | 1996-03-19 | 2003-04-11 | Janssen Pharmaceutica Nv | Fused imidazole derivatives as multidrug resistance modulators |
| AU4400597A (en) * | 1996-10-08 | 1998-05-05 | Fujisawa Pharmaceutical Co., Ltd. | Indole derivatives |
| WO1999050268A2 (en) | 1998-03-31 | 1999-10-07 | The Institutes For Pharmaceutical Discovery, Inc. | Substituted indolealkanoic acids |
| EP1070705A4 (de) * | 1998-04-06 | 2002-04-17 | Fujisawa Pharmaceutical Co | Indol-derivate |
| TNSN99224A1 (fr) | 1998-12-01 | 2005-11-10 | Inst For Pharm Discovery Inc | Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique |
| EP2335700A1 (de) | 2001-07-25 | 2011-06-22 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis C Virus Polymerase Inhibitoren mit heterobicylischer Struktur |
| US7098231B2 (en) * | 2003-01-22 | 2006-08-29 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
| US7223785B2 (en) * | 2003-01-22 | 2007-05-29 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
| TW200505913A (en) * | 2003-03-28 | 2005-02-16 | Hoffmann La Roche | Novel oxazole derivatives, their manufacture and use as pharmaceutical agents |
| GB0324763D0 (en) | 2003-10-23 | 2003-11-26 | Oxagen Ltd | Use of compounds in therapy |
| TWI368507B (en) * | 2004-02-20 | 2012-07-21 | Boehringer Ingelheim Int | Viral polymerase inhibitors |
| AU2005296305A1 (en) * | 2004-10-12 | 2006-04-27 | Decode Genetics Ehf | Sulfonamide peri-substituted bicyclics for occlusive artery disease |
| CA2618682C (en) * | 2005-08-12 | 2011-06-21 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
| EP2027117A2 (de) | 2006-05-16 | 2009-02-25 | Decode Genetics EHF | Verfahren zur herstellung von 7-(acryloyl)-indolen |
| PT2046740E (pt) | 2006-07-22 | 2012-08-28 | Oxagen Ltd | Compostos com atividade antagonista do crth2 |
| US7750027B2 (en) | 2008-01-18 | 2010-07-06 | Oxagen Limited | Compounds having CRTH2 antagonist activity |
| PT2250161E (pt) | 2008-01-18 | 2014-01-21 | Atopix Therapeutics Ltd | Compostos tendo atividade antagonista de crth2 |
| JP2011509991A (ja) | 2008-01-22 | 2011-03-31 | オキサジェン リミテッド | Ｃｒｔｈ２アンタゴニスト活性を有する化合物 |
| GB201322273D0 (en) | 2013-12-17 | 2014-01-29 | Atopix Therapeutics Ltd | Process |
| GB201407807D0 (en) | 2014-05-02 | 2014-06-18 | Atopix Therapeutics Ltd | Polymorphic form |
| GB201407820D0 (en) | 2014-05-02 | 2014-06-18 | Atopix Therapeutics Ltd | Polymorphic form |
| EP3798214B1 (de) | 2014-10-06 | 2022-09-14 | Vertex Pharmaceuticals Incorporated | Modulatoren des cftr-regulators |
| EP3436446B1 (de) | 2016-03-31 | 2023-06-07 | Vertex Pharmaceuticals Incorporated | Modulatoren des cystic fibrosis transmembrane conductance regulators |
| SG10201913595YA (en) | 2016-09-30 | 2020-02-27 | Vertex Pharma | Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator |
| MA49235B1 (fr) | 2016-12-09 | 2021-02-26 | Vertex Pharma | Modulateur de régulateur de conductance transmembranaire de fibrose kystique, compositions pharmaceutiques, procédés de traitement et procédé de fabrication du modulateur |
| EP3634402B1 (de) | 2017-06-08 | 2026-01-21 | Vertex Pharmaceuticals Incorporated | Verfahren zur behandlung von zystischer fibrose |
| BR112020000941A2 (pt) | 2017-07-17 | 2020-07-21 | Vertex Pharmaceuticals Incorporated | métodos de tratamento para fibrose cística |
| TWI799435B (zh) | 2017-08-02 | 2023-04-21 | 美商維泰克斯製藥公司 | 製備化合物之製程 |
| IL273831B2 (en) | 2017-10-19 | 2024-10-01 | Vertex Pharma | Crystalline forms and compositions of cftr modulators |
| CN111757874B (zh) | 2017-12-08 | 2024-03-08 | 弗特克斯药品有限公司 | 用于制备囊性纤维化跨膜传导调节因子的调节剂的方法 |
| TWI810243B (zh) | 2018-02-05 | 2023-08-01 | 美商維泰克斯製藥公司 | 用於治療囊腫纖化症之醫藥組合物 |
| US11414439B2 (en) | 2018-04-13 | 2022-08-16 | Vertex Pharmaceuticals Incorporated | Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator |
| SG11202107080VA (en) * | 2019-01-11 | 2021-07-29 | Naegis Pharmaceuticals Inc | Leukotriene synthesis inhibitors |
| US20230192684A1 (en) * | 2020-05-27 | 2023-06-22 | University Of Pittsburgh-Of The Commonwealth System Of Higher Higher Education | Substituted indoles with inhibitory activity |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5089495A (en) * | 1989-01-30 | 1992-02-18 | Imperial Chemical Industries Plc | Heterocyclic thiazole derivatives and pharmaceutical compositions comprising said derivatives |
| DE69009887T2 (de) * | 1989-07-26 | 1994-09-22 | Ici Pharma | Bizyklische Derivate. |
| PT95692A (pt) * | 1989-10-27 | 1991-09-13 | American Home Prod | Processo para a preparacao de derivados de acidos indole-,indeno-,piranoindole- e tetra-hidrocarbazole-alcanoicos, ou quais sao uteis como inibidores de pla2 e da lipoxigenase |
| US5254581A (en) * | 1990-06-21 | 1993-10-19 | Imperial Chemical Industries Plc | Pyran derivatives and their use as inhibitors of 5-lipoxygenase |
| IE911853A1 (en) * | 1990-06-21 | 1992-01-01 | Ici Plc | Heterocyclene derivatives |
| GB9113137D0 (en) * | 1990-07-13 | 1991-08-07 | Ici Plc | Thioxo heterocycles |
| AU654140B2 (en) * | 1990-07-31 | 1994-10-27 | Lilly Industries Limited | N-benzyl indoles, processes for their preparation or pharmaceutical compositions containing them |
| EP0505122A1 (de) * | 1991-03-21 | 1992-09-23 | Zeneca Limited | Alpha, Alpha-Dialkylbenzylderivate |
-
1991
- 1991-10-24 GB GB919122590A patent/GB9122590D0/en active Pending
-
1992
- 1992-10-16 DE DE69224697T patent/DE69224697T2/de not_active Expired - Fee Related
- 1992-10-16 AT AT92309461T patent/ATE163933T1/de not_active IP Right Cessation
- 1992-10-16 DK DK92309461T patent/DK0539117T3/da active
- 1992-10-16 ES ES92309461T patent/ES2113927T3/es not_active Expired - Lifetime
- 1992-10-16 EP EP92309461A patent/EP0539117B1/de not_active Expired - Lifetime
- 1992-10-16 US US07/962,365 patent/US5410061A/en not_active Expired - Fee Related
- 1992-10-22 CA CA002081133A patent/CA2081133A1/en not_active Abandoned
- 1992-10-23 JP JP4327193A patent/JPH05345778A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE69224697T2 (de) | 1998-07-16 |
| EP0539117A1 (de) | 1993-04-28 |
| CA2081133A1 (en) | 1993-04-25 |
| JPH05345778A (ja) | 1993-12-27 |
| DE69224697D1 (de) | 1998-04-16 |
| GB9122590D0 (en) | 1991-12-04 |
| ES2113927T3 (es) | 1998-05-16 |
| DK0539117T3 (da) | 1998-09-28 |
| EP0539117B1 (de) | 1998-03-11 |
| US5410061A (en) | 1995-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69224697D1 (de) | Verbindungen, nützlich als leukotriene Antagonisten | |
| FI913782A0 (fi) | Isoxazolderivat. | |
| PT634408E (pt) | Derivado de depsipeptido sua producao e utilizacao | |
| ID24166A (id) | Turunan piridazin baru dan obat-obatan yang mengandung hal yang sama sebagai ramuan efektif | |
| ATE214055T1 (de) | Retinoid-potenzierende verbindungen | |
| CY1109863T1 (el) | Παραγωγα θειαζολης για χρηση ως αντιφλεγμονωδη | |
| EP0556396A4 (en) | Substituted pyrazole derivative and agrohorticultural bactericide | |
| EP0632031A4 (de) | ||
| DE69918695D1 (de) | Sauerstoffhaltige heterocyclische verbindungen | |
| TR199500954A1 (tr) | Yeni pirokarbazoller. | |
| EA199900834A1 (ru) | Антивирусные средства | |
| ATE231491T1 (de) | Inhibitor des erwerbs der abhängigkeit/resistenz gegen betäaubende analgetika | |
| NO912963L (no) | Farmasoeytiske forbindelser. | |
| DE69429185D1 (de) | Imidazolidinon-derivate, deren säure-additionssalze und mittel gegen senile demenz | |
| DK0387489T3 (da) | Anvendelse af 2,2,6,6-tetramethyl-4-aminopiperidinamider som fungicider | |
| EA199900888A1 (ru) | Противоревматические средства | |
| DE69123757D1 (de) | Epoxysuccinamidsäurederivat | |
| ES2095281T3 (es) | Compuestos insecticidas y acaricidas de diarilpirrolcarbonitrilo y diarilnitropirrol. | |
| ECSP951403A (es) | Compuestos heterociclicos y fenilo | |
| TH13138A (th) | พิเพอราซินิลและพิเพอริดินิลไซโคลเฮกซานอล | |
| TH13153A (th) | อนุพันธ์ฟีนิลควินาโซลีนที่ถูกแทนที่ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |